Benitec Biopharma Limited

Press Releases

2015-December-9	Greg West, Benitec's Chief Financial Officer and Company Secretary, Appointed Interim Chief Executive Officer (in PDF)
2015-December-7	Benitec's Hepatitis B Therapeutic Shows Positive Preclinical Results (in PDF)
2015-November-12	Chairman's Address at the Annual General Meeting Held on Thursday 12 November 2015 (in PDF)
2015-October-22	Benitec Biopharma's Abstract Accepted for Presentation at the AASLD Liver Meeting 2015 (in PDF)
2015-October-19	Benitec Forms Hepatology Clinical Advisory Board (in PDF)
2015-October-7	Lonza and Benitec Enter Agreement to Develop Scalable AAV Manufacturing Process for ddRNAi Therapeutics (in PDF)
2015-October-1	Benitec CEO Discusses Arrowhead's Hepatitis B Results (in PDF)
2015-September-23	Benitec Featured at CHI's "Discovery On Target" Conference (in PDF)
2015-September-17	Clarification: Hepatitis C Clinical Trial Announcement (in PDF)
2015-September-16	Benitec Initiates a Fourth Site in Hepatitis C Clinical Trial (in PDF)
2015-August-24	CEO of Benitec Biopharma Discusses the Company's NASDAQ Listing (in PDF)
2015-August-24	Benitec Announces Closing of an Initial Public Offering in the United States with Listing on NASDAQ (in PDF)
2015-August-19	Benitec Announces Pricing of an Initial Public Offering in the United States with Listing on NASDAQ (in PDF)
2015-August-11	Update on Benitec US IPO (in PDF)
2015-July-22	Chairman's Address and Results of the General Meeting Held on Wednesday 22 July 2015 (in PDF)
2015-July-9	Benitec Acquires Full Rights to Hepatitis B Program (in PDF)
2015-July-3	RA Capital Substantial Shareholder Notice (in PDF)
2015-July-3	Benitec Enters Next Phase of Collaboration for Development of OPMD Therapeutic (in PDF)
2015-June-25	Hepatitis C Clinical Trial Update (in PDF)
2015-June-23	Benitec Announces Plans for an Initial Public Offering in the United States with Listing on NASDAQ (in PDF)
2015-June-22	Benitec Collaborates with ReNeuron on Cellular Therapies with Combined ddRNAi and Exosome Program (in PDF)
2015-June-19	ADR Ratio Changed (in PDF)
2015-May-25	Benitec Provides Update on Manufacturing of Clinical Trial Material (in PDF)
2015-May-18	Additional Patent Granted for Benitec's Hepatitis C Portfolio in the US (in PDF)
2015-May-4	Benitec Announces Confidential Submission of Draft Registration Statement for Initial Public Offering in the United States (in PDF)
2015-April-29	Benitec's Senior Vice President Research & Development Presents at Australian Gene Therapy Conference (in PDF)
2015-April-29	Update on Benitec's Hepatitis C Clinical Trial (in PDF)
2015-April-17	Benitec Executes License with Asklepios BioPharmaceutical (in PDF)
2015-April-7	Benitec Provides Update on TT-034 Trial (in PDF)
2015-March-11	Fourth Patient Dosed in Benitec's TT-034 Trial for Hepatitis C (in PDF)
2015-March-3	R&D Tax Credit Received (in PDF)
2015-March-3	Update on Benitec's TT-034 Trial for Hepatitis C (in PDF)
2015-March-2	Benitec's Licensed Platform RNAi Patent Succeeds in European Opposition (in PDF)
2015-February-26	Interim Report for the Half Year Ended December 31, 2014 (in PDF)
2015-January-8	Benitec Announces Publication of Independent Research, Supporting Tribetarna™ for Additional Cancer Indications (in PDF)
2015-January-7	Benitec Advances Hepatitis C Clinical Trial (in PDF)
2014	2014 Press Releases
2013	2013 Press Releases
2012	2012 Press Releases
2011	2011 Press Releases